RE:bioMedical Journal-the Lancet-2024 - Glioblastoma vaccines Yes the company did announce that on April 17th 2015 but they also announced this 2 months later.
Oncolytics Biotech® Inc. Provides Update at AGM on Planned Registration Program for REOLYSIN®
CALGARY, June 8, 2015 /PRNewswire/ – Oncolytics Biotech® Inc. (TSX:ONC, NASDAQ:ONCY) (“Oncolytics” or the “Company”) today provided an update on its planned registration program for REOLYSIN®, its proprietary formulation of the human reovirus, at its Annual General Meeting of Shareholders. The presentation highlights that:
The Company will initially focus on pursuing registration for REOLYSIN
® in two indications: the neoadjuvant treatment of muscle-invasive bladder cancer and the treatment of glioblastoma
Problem is they were planning 2 registration trials back in 2015 and never followed through. These trials were being planned and not much later the company had a change in management and the trials were never run. I had also heard at one time that a crc phase 3 trial was being planned.
We can have all the orphan drug statuses and fast tracks in the world but the company needs to follow up